Kura Oncology Files 8-K
Ticker: KURA · Form: 8-K · Filed: Jun 18, 2025 · CIK: 1422143
| Field | Detail |
|---|---|
| Company | Kura Oncology, INC. (KURA) |
| Form Type | 8-K |
| Filed Date | Jun 18, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, regulatory-filing
TL;DR
Kura Oncology filed an 8-K on 6/18 for a 6/12 event - details TBD.
AI Summary
Kura Oncology, Inc. filed an 8-K on June 18, 2025, reporting an event that occurred on June 12, 2025. The filing pertains to 'Other Events' and 'Financial Statements and Exhibits' but does not provide specific details on the nature of these events within the provided text.
Why It Matters
This filing indicates a material event has occurred for Kura Oncology, requiring disclosure to investors. The specific nature of the event is not detailed in the provided excerpt.
Risk Assessment
Risk Level: medium — The filing of an 8-K often signifies significant corporate events, but the lack of specific details in this excerpt makes it difficult to assess the immediate risk.
Key Numbers
- 001-37620 — Commission File Number (Identifies Kura Oncology's SEC filing history.)
- 61-1547851 — IRS Employer Identification No. (Tax identification for Kura Oncology.)
Key Players & Entities
- Kura Oncology, Inc. (company) — Registrant
- ZETA ACQUISITION CORP III (company) — Former Company Name
- June 12, 2025 (date) — Date of earliest event reported
- June 18, 2025 (date) — Date of Report
FAQ
What specific 'Other Events' are being reported by Kura Oncology?
The provided text does not specify the 'Other Events' being reported.
What 'Financial Statements and Exhibits' are included in this 8-K filing?
The provided text does not detail the specific 'Financial Statements and Exhibits' included.
What is the significance of the date June 12, 2025, for Kura Oncology?
June 12, 2025, is the date of the earliest event reported in this 8-K filing.
When was Kura Oncology previously known as ZETA ACQUISITION CORP III?
The date of the name change from ZETA ACQUISITION CORP III to Kura Oncology, Inc. was December 27, 2007.
What is Kura Oncology's principal executive office address?
Kura Oncology's principal executive offices are located at 12730 High Bluff Drive, Suite 400, San Diego, CA 92130.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 18, 2025 regarding Kura Oncology, Inc. (KURA).